MARC Record from marc_columbia

LEADER: 03204cam a2200565Ii 4500
001 15109826
005 20220514232853.0
006 m o d
007 cr cnu---unuuu
008 160225s2016 flu ob 000 0 eng d
035 $a(OCoLC)ocn940961578
035 $a(NNC)15109826
040 $aN$T$beng$erda$epn$cN$T$dN$T$dIDEBK$dOCLCF$dCOO$dOCLCQ$dSFB$dK6U$dOCLCO
019 $a941066081
020 $a9781482262735$qelectronic bk.
020 $a1482262738$qelectronic bk.
020 $z9781482262711
020 $z1482262711
035 $a(OCoLC)940961578$z(OCoLC)941066081
037 $a899790$bMIL
050 4 $aRS199.5$b.N368 2016
072 7 $aMED$x071000$2bisacsh
082 04 $a615.1/9$223
049 $aZCUA
245 00 $aNanotechnology and drug delivery.$nVolume 2,$pNano-engineering strategies and nanomedicines against severe diseases /$ceditor, José L. Arias.
246 3 $aNano-engineering strategies and nanomedicines against severe diseases
264 1 $aBoca Raton :$bCRC Press,$c[2016]
264 4 $c©2016
300 $a1 online resource
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
588 0 $aOnline resource; title from PDF title page (EBSCO, viewed March 17, 2016)
504 $aIncludes bibliographical references.
500 $a"A Science Publishers Book."
505 0 $aChapter 1: Emerging technologies of polymers for nanomedicine applications -- Chapter 2: Nanotechnology for oral drug delivery and targeting -- Chapter 3: Nanoparticulate systems for dental drug delivery -- Chapter 4: Nanotechnology for topical and transdermal drug delivery and targeting -- Chapter 5: Nanotechnology for pulmonary and nasal drug delivery -- Chapter 6: Lipid nanoplatforms for pulmonary drug delivery -- Chapter 7: Nanotechnology for ocular and otic drug delivery and targeting -- Chapter 8: Nanotechnology for veginal drug deliver and and targeting -- Chapter 9: Potential nanocarriers for brain drug deliver -- Chapter 10: Nanomaterials and cancer therapy -- Chapter 11: Nanomedicine in cardiovascular disease
505 8 $aChapter 12: Nano(Neuro)medicinal interventions for neurodegenerative disorders: a meta-analysis of concurrent challeges and strategic solutions -- Chapter 13: Nanomedicines against infectious diseases -- Chapter 14: Nanomedicines against chronic inflammatory diseases -- Chapter 15: Nanomedicine biopharmaceuticals for metabolic diseases -- Chapter 16: Nanotechnology in gene knockdown and miRNA replacement in Vivo -- Chapter 17: Nanotheranostics.
650 0 $aDrug delivery systems.
650 0 $aNanomedicine.
650 2 $aDrug Delivery Systems
650 6 $aSystèmes d'administration de médicaments.
650 7 $aMEDICAL / Pharmacology$2bisacsh
650 7 $aDrug delivery systems.$2fast$0(OCoLC)fst00898667
650 7 $aNanomedicine.$2fast$0(OCoLC)fst01744350
655 0 $aElectronic books.
655 4 $aElectronic books.
655 7 $aElectronic books.$2local
700 1 $aArias, José L.,$eeditor.
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio15109826$zTaylor & Francis eBooks
852 8 $blweb$hEBOOKS